Current advances in cancer vaccines targeting NY-ESO-1 for solid cancer treatment

Current advances in cancer vaccines targeting NY-ESO-1 for solid cancer treatment

New York-esophageal cancer 1 (NY-ESO-1) belongs to the cancer testis antigen (CTA) family, and has been identified as one of the most immunogenic tumor-associated antigens (TAAs) among the family members. Given its ability to trigger spontaneous humoral and cellular immune response and restricted ex...

Full description

Bibliographic Details
Main Authors: Hong Zhou, Yipeng Ma, Fenglan Liu, Bin Li, Dongjuan Qiao, Peigen Ren, Mingjun Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Immunology
Subjects:
CTA
NY-ESO-1
cancer vaccine
immunotherapy
solid cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1255799/full

Similar Items

Similar Items